Fludarabine, cyclophosphamide, and multiple‐dose rituximab as frontline therapy for chronic lymphocytic leukemia

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|121|21|3869-3876

ISSN: 0008-543x

Source: CANCER, Vol.121, Iss.21, 2015-11, pp. : 3869-3876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content